Guangdong Transtek Medical Electronics Co Ltd
Guangdong Transtek Medical Electronics Co., Ltd. engages in the research and development, design, manufacturing, operation services, and sales of medical, health, and smart wearable products in China and internationally. The company offers health products, including smart electronic blood pressure monitors, electronic health scales, smart blood sugar monitoring products, fat meters, and ECG monit… Read more
Guangdong Transtek Medical Electronics Co Ltd (300562) - Net Assets
Latest net assets as of September 2025: CN¥992.41 Million CNY
Based on the latest financial reports, Guangdong Transtek Medical Electronics Co Ltd (300562) has net assets worth CN¥992.41 Million CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥1.42 Billion) and total liabilities (CN¥427.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥992.41 Million |
| % of Total Assets | 69.9% |
| Annual Growth Rate | 23.48% |
| 5-Year Change | 49.08% |
| 10-Year Change | 334.72% |
| Growth Volatility | 35.4 |
Guangdong Transtek Medical Electronics Co Ltd - Net Assets Trend (2011–2024)
This chart illustrates how Guangdong Transtek Medical Electronics Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Guangdong Transtek Medical Electronics Co Ltd (2011–2024)
The table below shows the annual net assets of Guangdong Transtek Medical Electronics Co Ltd from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥976.51 Million | -4.65% |
| 2023-12-31 | CN¥1.02 Billion | +2.54% |
| 2022-12-31 | CN¥998.78 Million | -4.64% |
| 2021-12-31 | CN¥1.05 Billion | +59.90% |
| 2020-12-31 | CN¥655.01 Million | +15.31% |
| 2019-12-31 | CN¥568.05 Million | +6.78% |
| 2018-12-31 | CN¥531.97 Million | +3.44% |
| 2017-12-31 | CN¥514.28 Million | +1.60% |
| 2016-12-31 | CN¥506.16 Million | +125.33% |
| 2015-12-31 | CN¥224.63 Million | +19.01% |
| 2014-12-31 | CN¥188.74 Million | +54.38% |
| 2013-12-31 | CN¥122.26 Million | +33.53% |
| 2012-12-31 | CN¥91.56 Million | +45.57% |
| 2011-12-31 | CN¥62.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Guangdong Transtek Medical Electronics Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 753.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥229.11 Million | 23.00% |
| Common Stock | CN¥217.47 Million | 21.83% |
| Other Components | CN¥549.60 Million | 55.17% |
| Total Equity | CN¥996.17 Million | 100.00% |
Guangdong Transtek Medical Electronics Co Ltd Competitors by Market Cap
The table below lists competitors of Guangdong Transtek Medical Electronics Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HAVERTY FURNITURE A DL 1
F:25F0
|
$269.95 Million |
|
Chang Lan Electric Technology Co Ltd
SHE:002879
|
$269.96 Million |
|
Sinosteel Luonai Materials Technology Co. Ltd. A
SHG:688119
|
$270.01 Million |
|
Bosung Power Technology Co. Ltd
KQ:006910
|
$270.01 Million |
|
Hangzhou Prevail Optoelectronic Equipment Co Ltd
SHE:300710
|
$269.86 Million |
|
Orthopediatrics Corp
NASDAQ:KIDS
|
$269.82 Million |
|
Fujian Minfa Aluminium Co Ltd
SHE:002578
|
$269.78 Million |
|
Shift Up Corporation
KO:462870
|
$269.78 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Guangdong Transtek Medical Electronics Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,040,603,601 to 996,172,799, a change of -44,430,802 (-4.3%).
- Net income of 61,364,226 contributed positively to equity growth.
- Dividend payments of 65,208,102 reduced retained earnings.
- Other comprehensive income decreased equity by 90,226,057.
- Other factors increased equity by 49,639,131.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥61.36 Million | +6.16% |
| Dividends Paid | CN¥65.21 Million | -6.55% |
| Other Comprehensive Income | CN¥-90.23 Million | -9.06% |
| Other Changes | CN¥49.64 Million | +4.98% |
| Total Change | CN¥- | -4.27% |
Book Value vs Market Value Analysis
This analysis compares Guangdong Transtek Medical Electronics Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.94x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 29.19x to 2.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥0.47 | CN¥13.61 | x |
| 2012-12-31 | CN¥0.68 | CN¥13.61 | x |
| 2013-12-31 | CN¥0.91 | CN¥13.61 | x |
| 2014-12-31 | CN¥1.38 | CN¥13.61 | x |
| 2015-12-31 | CN¥1.59 | CN¥13.61 | x |
| 2016-12-31 | CN¥3.46 | CN¥13.61 | x |
| 2017-12-31 | CN¥2.58 | CN¥13.61 | x |
| 2018-12-31 | CN¥2.87 | CN¥13.61 | x |
| 2019-12-31 | CN¥3.01 | CN¥13.61 | x |
| 2020-12-31 | CN¥3.45 | CN¥13.61 | x |
| 2021-12-31 | CN¥4.92 | CN¥13.61 | x |
| 2022-12-31 | CN¥4.71 | CN¥13.61 | x |
| 2023-12-31 | CN¥4.85 | CN¥13.61 | x |
| 2024-12-31 | CN¥4.62 | CN¥13.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Guangdong Transtek Medical Electronics Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 6.16%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.24%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 1.52x
- Recent ROE (6.16%) is below the historical average (13.50%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 35.39% | 9.55% | 2.00x | 1.85x | CN¥15.97 Million |
| 2012 | 31.31% | 8.86% | 2.02x | 1.75x | CN¥19.51 Million |
| 2013 | 28.76% | 9.23% | 1.74x | 1.79x | CN¥22.94 Million |
| 2014 | 24.02% | 9.95% | 1.56x | 1.55x | CN¥26.47 Million |
| 2015 | 22.34% | 7.98% | 1.84x | 1.52x | CN¥27.73 Million |
| 2016 | 15.91% | 10.45% | 1.16x | 1.31x | CN¥29.90 Million |
| 2017 | 3.48% | 2.06% | 1.15x | 1.47x | CN¥-33.37 Million |
| 2018 | 4.52% | 3.10% | 0.88x | 1.65x | CN¥-29.08 Million |
| 2019 | 5.47% | 3.52% | 0.90x | 1.73x | CN¥-25.75 Million |
| 2020 | 10.74% | 5.25% | 0.97x | 2.12x | CN¥4.81 Million |
| 2021 | 0.84% | 0.49% | 1.01x | 1.70x | CN¥-96.61 Million |
| 2022 | -3.19% | -3.03% | 0.69x | 1.53x | CN¥-133.50 Million |
| 2023 | 3.30% | 3.89% | 0.57x | 1.50x | CN¥-69.69 Million |
| 2024 | 6.16% | 6.24% | 0.65x | 1.52x | CN¥-38.25 Million |
Industry Comparison
This section compares Guangdong Transtek Medical Electronics Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Guangdong Transtek Medical Electronics Co Ltd (300562) | CN¥992.41 Million | 35.39% | 0.43x | $269.89 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |